Amide compounds with MCH antagonistic activity and medicaments comprising these compounds

US7592373B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Thorsten Lehmann-Lintz · Ochsenhausen, DE
• Ralf Lotz · Schemmerhofen, DE
• Philipp Lustenberger · Warthausen, DE
• Stephan Georg Mueller · Warthausen, DE
• Gerald Juergen Roth · Biberach, DE
• Klaus Rudolf · Warthausen, DE
• Marcus Schindler · Schwäbisch Hall, DE
• Dirk Stenkamp · Biberach, DE
• Leo Thomas · Biberach, DE

Key dates

• Filing date: Dec 23, 2004
• Grant date: Sep 22, 2009
• Expiry date: May 7, 2026

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2601/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds of formula (I)wherein A, B, b, W, X, Y, Z, R1, R2, and R3 have the meanings given in claim 1, pharmaceutical compositions these compounds, and methods of preventing or treating metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia, and diabetes using these compounds.